Search

Search Constraints

You searched for: Author/Creator Vansteenkiste, Johan

Search Results

41. Phase III, randomized, open-label study of durvalumab (MEDI4736) in combination with tremelimumab or durvalumab alone versus platinum-based chemotherapy in first-line treatment of patients with advanced/metastatic NSCLC: MYSTIC. (4th November 2015)

44. Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics. (October 2013)

45. Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET–CT for delineation?. Issue 2 (August 2016)

46. Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis. Issue 9 (28th September 2022)

47. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer. (April 2022)

48. The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database. (December 2016)

49. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. Issue 5 (May 2016)

50. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. Issue 5 (May 2016)